Company Filing History:
Years Active: 2021-2024
Title: Norzehan Abdul-Manan: Innovator in Genome Editing
Introduction
Norzehan Abdul-Manan is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of genome editing, holding 2 patents that focus on enhancing the efficiency of genetic modifications. His work is crucial in advancing the capabilities of genetic engineering.
Latest Patents
Abdul-Manan's latest patents include innovative methods, compositions, and kits designed to increase genome editing efficiency. These patents detail methods for editing target genomic regions, repairing DNA breaks via HDR pathways, and inhibiting repair through NHEJ pathways. Additionally, they describe methods for modifying gene or protein expression by administering a genome editing system along with a DNA protein-kinase (DNA-PK) inhibitor. The kits and compositions he developed are essential for editing target genes effectively.
Career Highlights
Norzehan Abdul-Manan is currently employed at Vertex Pharmaceuticals, Inc., where he continues to push the boundaries of genetic research. His work at Vertex has positioned him as a key player in the biotechnology industry, contributing to groundbreaking advancements in genome editing technologies.
Collaborations
Abdul-Manan collaborates with notable colleagues, including David A Newsome and Jacque Zwahlen. These partnerships enhance the innovative potential of his research and contribute to the success of their projects.
Conclusion
Norzehan Abdul-Manan is a leading figure in the field of genome editing, with a focus on improving the efficiency of genetic modifications. His patents and work at Vertex Pharmaceuticals, Inc. reflect his commitment to advancing biotechnology.